Global Gene Therapy Market 2018-2022| 22% CAGR Projection Over the Next Four Years | Technavio
LONDON--(BUSINESS WIRE)--Sep 24, 2018-- analysts forecast the global gene therapy market to grow at a CAGR of over 22% during the forecast period, according to their latest market research report.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180924005535/en/
Technavio has published a new market research report on the global gene therapy market for the period 2018-2022. (Graphic: Business Wire)
The growing research in gene therapy for CVDs and orphan disease is one of the major trends being witnessed in the . The increasing prevalence of CVDs and the urgency to treat the diseases in less time led the major pharmaceutical players investing heavily in the R&D of novel therapies that are highly effective, including gene therapy.
According to Technavio analysts, one of the key factors contributing to the growth of the global gene therapy market is the market entry of novel molecules during the forecast period:
Global gene therapy market: Market entry of novel molecules during the forecast period
Gene therapy is currently one of the most advanced treatment methods in the pharmaceutical industry. The has 34 therapies in the advanced stages of clinical trials and over 400 therapies in the early stages.
According to a senior analyst at Technavio for research on infectious and rare diseases, “The gene therapies that are in the advanced stages of development are expected to get approved and enter the market during the forecast period, which will stimulate the market growth. For instance, AVXS-101 is a gene therapy that is in the Phase III stage of clinical trials for the treatment of SMA.”
Global gene therapy market: Segmentation analysis
The global gene therapy market research report provides market segmentation by therapy area (oncology, CNS, ophthalmology, and rare diseases) and by region (the Americas, EMEA, and APAC). It provides an in-depth analysis of the prominent factors influencing the market, including drivers, opportunities, trends, and industry-specific challenges.
Of the major therapies, the oncology segment held the largest market share in 2017, contributing to over 38% of the market. This therapy will dominate the global market throughout the forecast period.
The Americas held the largest share of the market in 2017, accounting for close to 54% share. It was followed by EMEA and APAC respectively. The region is expected to retain its dominance during the forecast period due to the well-defined health infrastructure in the US and the increasing initiatives taken by the US government.
Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.
Some of the key topics covered in the report include:
Market LandscapeMarket ecosystem Market characteristics Market segmentation analysis
Market SizingMarket definition Market size and forecast
Five Forces Analysis
Geographical SegmentationRegional comparison Key leading countries
Vendor LandscapeVendors covered Vendor classification Market positioning of vendors Competitive scenario
is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at .
View source version on businesswire.com:https://www.businesswire.com/news/home/20180924005535/en/
CONTACT: Technavio Research
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
KEYWORD: NORTH AMERICA CENTRAL AMERICA SOUTH AMERICA
INDUSTRY KEYWORD: HEALTH GENETICS PHARMACEUTICAL
SOURCE: Technavio Research
Copyright Business Wire 2018.
PUB: 09/24/2018 08:57 AM/DISC: 09/24/2018 08:57 AM